EquityZen Growth Technology Fund LLC - Series 1956
Raised
$145K
Investors
10
Min Invest
$5,000
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1956 is a Delaware LLC filed by EquityZen Advisors LLC and Phil Haslett on 2024-10-21, raising $145K from 10 investors under Rule 506(b) and 3(c)(1) exemptions. The fund offers a $5K minimum investment and is part of EquityZen's platform of nearly 1,900 pre-IPO SPV vehicles providing access to private growth-stage technology companies.
This pre-IPO pooled investment fund uses the standard 506(b)/3(c)(1) exemption structure typical of EquityZen's single-company SPV model. The $5K minimum investment is consistent with EquityZen's retail-accessible positioning, enabling smaller investors to gain exposure to private technology companies through a series vehicle structure.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Phil Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
